-

Cannabis Science and Technology Adds William Z. Levine, D.D.S., to Editorial Advisory Board

Dr. Levine will contribute to educating Cannabis Science and Technology’s™ readers and the cannabis community as a whole

CRANBURY, N.J.--(BUSINESS WIRE)--Cannabis Science and Technology™—a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation—is proud to announce the addition of William Z. Levine, D.D.S., to its editorial advisory board.

“We look forward to having Dr. Levine joining the Cannabis Science and Technology™ advisory board,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of Cannabis Science and Technology™. “His experience and contributions will be a great asset to our editorial staff as we continue to deliver unprecedented content to our readers.”

Levine is the founder of Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in botanical medicine. This area of specialty pharma develops pharmaceutical and health care products from plant-based sources. Levine, who received his D.D.S. degree and specialty training in periodontics from Columbia University, initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. Izun has also developed wound care products, oncology support products, and products targeting women’s health care.

Subsequently, recognizing the Izun expertise in botanicals, Levine applied this knowledge to the cannabis plant and established CannRx. In a short time, CannRx has developed novel targeted formulations, highly effective drug delivery systems specifically designed for cannabis, and completely new extraction systems.

As a member of the advisory board, Levine will work closely with the editorial team and the existing 16 board members to recommend topics, solicit and provide content, and share breaking news and information on the latest happenings in the cannabis industry.

For more information about the Cannabis Science and Technology™ editorial advisory board, click here.

About Cannabis Science and Technology

Cannabis Science and Technology™ is a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation. The magazine is accompanied by an online component and provides relevant information and tutorials for all members of the cannabis industry. Cannabis Science and Technology™ is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

Contacts

Cannabis Science and Technology Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhlifesciences.com

Cannabis Science and Technology


Release Summary
Cannabis Science and Technology™ Adds William Z. Levine, D.D.S., to Editorial Advisory Board
Release Versions

Contacts

Cannabis Science and Technology Media
Alexandra Ventura, 609-716-7777, ext. 121
aventura@mjhlifesciences.com

Social Media Profiles
More News From Cannabis Science and Technology

CURE Media Group Announces the 2021 Extraordinary Healer® Award for Oncology Nursing Finalists

CRANBURY, N.J.--(BUSINESS WIRE)--3 exceptional nurses will be honored alongside the Finest Hour award winner, who has provided care in patients’ lives during the COVID-19 pandemic....

Urology Times® Welcomes Michael S. Cookson, M.D., and Gopal Badlani, M.D., as Co-Editors in Chief

CRANBURY, N.J.--(BUSINESS WIRE)--Both medical professionals bring experience and expertise that will elevate the future work of the publication...

Pharmacy Times ® Adds Five Notable New Partners to its Strategic Alliance Partnership Program

CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading multimedia resource for pharmacy professionals, is excited to announce that it has expanded its Strategic Alliance Partnership (SAP) program roster with the addition of five new partners. “This past quarter we have formed multiple partnerships with exceptional oncology and health system pharmacy leaders, strengthening our position in the pharmacy industry,” said Gil Hernandez, vice president of Pharmacy & Healthcare Communication...
Back to Newsroom